Medical/Pharmaceuticals
KAHR Medical Raises $18 Million in Private Funding Round
Funds will be used for advancing the Company's next generation immuno-oncology
drug candidates, including lead anti-CD47 product for the treatment of solid
tumors through Phase I/II study in addition to advancing preclinical pipeline
JERUSALEM, Feb. 26, 2020 /PRNewswire/ -- KAHR Medical
2020-02-26 08:30
WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19
SAN FRANCISCO and SHANGHAI, Feb. 25, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Vir Biotechnology, Inc. ("Vir") (Nasdaq: VI...
2020-02-25 21:30
279
Connect Biopharma Enhances its Intellectual Property Estate for CBP-307, a Targeted Therapy with Potential in Multiple Autoimmune Diseases, with Patent Issuances in the United States, EU, Japan and Australia
Novel, next-generation S1P1 agonist currently in Phase 2 clinical development for treatment of inflammatory bowel disease SAN DIEGO and TAICANG, China, Feb. 25, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on identifying and developing potent and spe...
2020-02-25 21:00
289
InDex Pharmaceuticals Publishes Mechanism of Action Data for Cobitolimod in Scientific Journal
STOCKHOLM, Feb. 25, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced the publication of scientific data on the mechanism of action of cobitolimod, the company's lead drug candidate in development for the treatment of moderate to severe ulcerative colitis. The paper, pu...
2020-02-25 15:26
392
U.S. FDA accepts GSK's sNDA application for Zejula (niraparib) for first-line maintenance treatment for women with platinum-responsive advanced ovarian cancer
- Submission based on data from the Phase III PRIMA clinical study that demonstrated clinically-meaningful outcomes of niraparib maintenance treatment in the first-line setting regardless of biomarker status - The application is being reviewed under the FDA's Real-Time Oncology Review pilot pr...
2020-02-24 22:00
585
Nearly VND 20 billion sponsored by Vingroup for research projects on response to novel coronavirus
HANOI, Vietnam, Feb. 21, 2020 /PRNewswire/ -- 3 units funded by Vingroup
Innovation Foundation (VINIF) include The Company for Vaccine and Biological
Production No.1 (Vabiotech), Pasteur Institute inHo Chi Minh City and Institute
of Preventive Medicine and Public Health.
2020-02-21 10:09
1321
S-CELL Becomes the First in Asia to Introduce Consumer Epigenetics Testing and is the Most Advanced Test in the World
HONG KONG, Feb. 21, 2020 /PRNewswire/ -- S-CELL, in partnership with Chronomics, is the first company inAsia to introduce Healthspan, the most advanced epigenetic testing service in the world. Chronomics was established in 2017 and later officially launched the epigenetics testing kit in hopes to...
2020-02-21 09:20
1371
Sihuan Pharmaceutical Announces Acquisition of All Interests and Intellectual Property Rights of Plazomicin, A New Generation of Aminoglycoside Antibiotics in the Greater China Region
HONG KONG, Feb. 20, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that Xuanzhu (HK) Biopharmaceutical Limited (''Xuanzhu''), a wholly-owned subsidiary of the...
2020-02-20 18:59
5486
Hummingbird Bioscience Announces Agreement with Mycenax Biotech for Production of Anti-VISTA Antibody HMBD-002 for Cancer Clinical Trial
HOUSTON, Feb. 20, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery of new breakthrough antibody therapeutics for difficult-to-treat conditions, today announced it has signed an agreement with Mycenax Biotech for the production of material...
2020-02-20 15:15
1083
InDex Pharmaceuticals' In-depth Analysis of the CONDUCT Study Confirms the Successful Top Line Results and Supports the Strategy Going Forward
STOCKHOLM, Feb. 20, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced the conclusions from in-depth analysis of the complete data set from the phase IIb dose optimisation study CONDUCT, evaluating the first-in-class TLR9 agonist cobitolimod for the treatment of moderate...
2020-02-20 06:00
1145
Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics
MADISON, Wisconsin, Feb. 20, 2020 /PRNewswire/ -- Nimble Therapeutics, Inc. today announced a multi-year collaboration with Genentech, a member of the Roche Group, to accelerate discovery and development of novel peptide-based medicines for targets across a range of diseases. The collaboration w...
2020-02-20 01:00
1315
NeuroVive Pharmaceutical AB Year End Report January - December 2019
STOCKHOLM, Feb. 19, 2020 /PRNewswire/ -- Important events in 2019 KL1333 * NeuroVive enrolls first subject in its European KL1333 phase Ia/b clinical study * NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study * NeuroVive compl...
2020-02-19 16:08
5085
Covaris launches novel viral RNA extraction kits for swab sample collection devices
- Covaris announced new kits for efficient viral RNA extraction from sterile, synthetic swabs - Covaris is supporting customers evaluating kits as a key component in the development of accurate COVID-19 virus detection assays WOBURN, Massachusetts, Feb. 18, 2020 /PRNewswire/ -- Covaris, Inc. tod...
2020-02-18 23:00
893
Sunon Charity Foundation Donates over $1.43 million to Fight the Novel Coronavirus
SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- As the novel coronavirus outbreak in Wuhan spreads, Sunon Charity Foundation acted quickly and in unity to fight against this disease. OnJanuary 28, Sunon provided an initial $1.43million to relief and containment efforts. Leveraging its global network and ...
2020-02-18 21:32
612
WuXi Biologics' Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader
SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that WuXi Vaccines, its joint venture with Shanghai ...
2020-02-18 18:42
201
Sihuan Pharmaceutical: Production Approval Granted For Rivastigmine Hydrogen Tartrate Capsule, The First Drug Passing Consistency Evaluation And Levetiracetam Tablet And The First Registration Approval Granted For Midazolam Oromucosal Solution
HONG KONG, Feb. 18, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that rivastigmine hydrogen tartrate capsule and levetiracetam tablet developed by the Group...
2020-02-18 18:07
5347
MMI SpA Appoints Ryan Rhodes as Chief Commercial Officer
CALCI, Italy, Feb. 18, 2020 /PRNewswire/ -- MMI SpA, an Italian company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today the appointment ofRyan Rhodes to the position of Global Chief Commercial Officer. Mr. Rhodes brings nearly 30 years of experience...
2020-02-18 16:00
808
Ascletis' IND Filing for Its Non-alcoholic Steatohepatitis (NASH) Drug Accepted by NMPA
HANGZHOU, China and SHAOXING, China, Feb. 18, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today the application for in-house developed Category 1 Drug ASC41 for clinical trials of NASH indication has been accepted byChina's National Medical Products Administration (NMPA)...
2020-02-18 08:00
948
Seegene launches KFDA Approved COVID-19 Assay
SEOUL, South Korea, Feb. 18, 2020 /PRNewswire/ -- Korea Centers for Disease Control & Prevention notified Seegene Inc. (096530.KQ) that Korea Ministry of Food and Drug Safety (MFDS; Former KFDA) approved its novel coronavirus (COIVD-19) Real-time PCR assay for the Emergency Use, following the rec...
2020-02-18 08:00
637
A New Expert Consensus Publication Provides Practical Guidance on the Use of Omega-3 Fatty Acids in Parenteral Nutrition
BAD HOMBURG, Germany, Feb. 17, 2020 /PRNewswire/ -- Fresenius Kabi, a global leader in clinical nutrition, announces that the Journal of Parenteral and Enteral Nutrition (JPEN) has recently published "Lipids in Parenteral Nutrition: Translating Guidelines into Clinical Practice".[1] The publicati...
2020-02-17 17:00
1447
Week's Top Stories
Most Reposted
The first information security ecosystem built by Vietnamese
[Picked up by 96 media titles]
2020-02-20 16:21Zoomlion Takes Steps to Combat the Novel Coronavirus (Covid-2019) Outbreak
[Picked up by 94 media titles]
2020-02-21 15:36
Vietnamese-based interactive music company Amanotes ranks among the top mobile app publishers worldwide
[Picked up by 91 media titles]
2020-02-19 11:00
Huawei Launches HiCampus Solution Globally
[Picked up by 91 media titles]
2020-02-20 23:53
Gamuda Land Adopts Yardi Elevate for Leasing and Deal Management
[Picked up by 87 media titles]
2020-02-21 06:00Most Read
How Toshiba Uses Structural Health Monitoring to Combat Aging Population and Aging Infrastructure
2020-02-19 10:00
8822
From Intern to Digital Transformation Leader: HKBN Proudly Appoints Samuel Hui as Chief Transformation Officer
2020-02-19 13:51
5687
